Recombinant CCR2 (Plozalizumab Biosimilar) 抗体
The Mammalian Cells 单克隆 anti-CCR2 (Plozalizumab Biosimilar) antibody is suitable to detect CCR2 (Plozalizumab Biosimilar) in samples from 人. It has been validated for ELISA.
产品编号 ABIN7488078
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant CCR2 (Plozalizumab Biosimilar) 抗体 (ABIN7488078)
抗原
CCR2 (Plozalizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This CCR2 (Plozalizumab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Plozalizumab Biosimilar - Anti-CCR2, CD192 mAb
-
产品特性
- Antibody Type: IgG1-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG1 kappa
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- CCR2 (Plozalizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
MLN-1202,anti-CCR2,hu1D9
Plozalizumab is a humanized monoclonal antibody that targets CCR2 chemokine receptors found on the surface of white blood cells such as macrophages and monocytes. Plozalizumab has been investigated to treat Atherosclerosis. CCR2 is supposed to play an important role in the trafficking of monocytes and macrophages to sites of inflammation. -
CAS-编号
- 1610761-46-0
抗原
-
You are here:
